{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T02:37:14Z","timestamp":1772678234804,"version":"3.50.1"},"reference-count":37,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Pfizer"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Variant transthyretin amyloidosis cardiomyopathy (ATTRv-CM) is a rare form of cardiac amyloidosis associated with many possible mutations in the transthyretin gene, presenting as various distinct clinical phenotypes. Among these, the His108Arg mutation is the most prevalent TTR variant in Austria. However, data describing its clinical phenotype are lacking. This study aims to describe the characteristics, clinical manifestations, and outcomes of patients with the His108Arg variant focusing on cardiac involvement, disease progression, response to therapy, and imaging findings. Methods: Patients were enrolled from a prospective cardiac amyloidosis registry. The baseline assessment included comprehensive echocardiography, cardiac magnetic resonance imaging, a biomarker analysis, and a clinical evaluation. Patients were followed longitudinally, with outcomes such as arrhythmias, heart failure hospitalizations, and response to disease-targeted therapies recorded. Results: Between March 2012 and June 2024, a total of 20 carriers of the His108Arg variant were identified, with 12 exhibiting clear cardiac involvement and 8 remaining asymptomatic. The median age at diagnosis was 62.3 years with significant heterogeneity in the clinical presentation. Patients with ATTRv-CM had a high prevalence of atrial and ventricular arrhythmias, a reduced left ventricular ejection fraction, and elevated cardiac biomarkers. The majority received specific disease-modifying therapies, with varying tolerance and responses. A longitudinal follow-up indicated frequent arrhythmic events, heart failure exacerbations, and three cases of heart transplantation, underscoring the need for stringent monitoring and individualized management strategies. Conclusions: This study represents a unique, comprehensive analysis of the His108Arg variant in ATTR-CM, highlighting its clinical heterogeneity and significant impact on cardiac function and clinical outcomes.<\/jats:p>","DOI":"10.3390\/jcm13247857","type":"journal-article","created":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T10:58:55Z","timestamp":1734951535000},"page":"7857","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["His108Arg Transthyretin Amyloidosis\u2014Shedding Light on a Distinctively Malignant Variant"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6060-7910","authenticated-orcid":false,"given":"Christina","family":"Binder","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Division of Cardiology, Medical University of Vienna, 1090 Wien, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0391-8545","authenticated-orcid":false,"given":"Lena Marie","family":"Schmid","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Cardiology, Medical University of Vienna, 1090 Wien, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3866-3710","authenticated-orcid":false,"given":"Christina","family":"Kronberger","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Cardiology, Medical University of Vienna, 1090 Wien, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6091-9823","authenticated-orcid":false,"given":"Michael","family":"Poledniczek","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Cardiology, Medical University of Vienna, 1090 Wien, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6409-5158","authenticated-orcid":false,"given":"Ren\u00e9","family":"Rettl","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Cardiology, Medical University of Vienna, 1090 Wien, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8426-5038","authenticated-orcid":false,"given":"Johanna","family":"Schlein","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Medical University of Vienna, 1090 Wien, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikita","family":"Ermolaev","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Cardiology, Medical University of Vienna, 1090 Wien, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8690-8113","authenticated-orcid":false,"given":"Luciana Camuz","family":"Ligios","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Cardiology, Medical University of Vienna, 1090 Wien, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michaela","family":"Auer-Grumbach","sequence":"additional","affiliation":[{"name":"Department of Orthopedics and Trauma Surgery, Medical University of Vienna, 1090 Wien, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Hengstenberg","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Cardiology, Medical University of Vienna, 1090 Wien, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roza Badr","family":"Eslam","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Cardiology, Medical University of Vienna, 1090 Wien, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Kastner","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Cardiology, Medical University of Vienna, 1090 Wien, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2591-1380","authenticated-orcid":false,"given":"Jutta","family":"Bergler-Klein","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Cardiology, Medical University of Vienna, 1090 Wien, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7632-9879","authenticated-orcid":false,"given":"Andreas Anselm","family":"Kammerlander","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Cardiology, Medical University of Vienna, 1090 Wien, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7519-5274","authenticated-orcid":false,"given":"Franz","family":"Duca","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Cardiology, Medical University of Vienna, 1090 Wien, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/cge.12500","article-title":"Frequencies and geographic distributions of genetic mutations in transthyretin- and non-transthyretin-related familial amyloidosis","volume":"88","author":"Zhen","year":"2015","journal-title":"Clin. Genet."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s13023-023-02962-5","article-title":"A 15-year consolidated overview of data in over 6000 patients from the Transthyretin Amyloidosis Outcomes Survey (THAOS)","volume":"18","author":"Gentile","year":"2023","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Auer-Grumbach, M., Rettl, R., Ablasser, K., Agis, H., Beetz, C., Duca, F., Gattermeier, M., Glaser, F., Hacker, M., and Kain, R. (2020). Hereditary ATTR Amyloidosis in Austria: Prevalence and Epidemiological Hot Spots. J. Clin. Med., 9.","DOI":"10.3390\/jcm9072234"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3233\/JND-210656","article-title":"Hereditary Transthyretin Amyloidosis- Clinical and Genetic Characteristics of a Multiracial South-East Asian Cohort in Singapore","volume":"8","author":"Chen","year":"2021","journal-title":"J. Neuromuscul. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ejmg.2015.02.005","article-title":"A genealogical and clinical study of the phenotypical variation within the Swedish transthyretin His88Arg (p. His108Arg) amyloidosis family","volume":"58","author":"Hellman","year":"2015","journal-title":"Eur. J. Med. Genet."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC Guidelines for the management of cardiomyopathies: Developed by the task force on the management of cardiomyopathies of the European Society of Cardiology (ESC)","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_7","first-page":"1076","article-title":"2023 ACC Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient with Cardiac Amyloidosis","volume":"81","author":"Kittleson","year":"2023","journal-title":"Circ."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1093\/eurheartj\/ehad281","article-title":"Expanding indications for non-biopsy diagnosis of transthyretin amyloid cardiomyopathy","volume":"44","author":"Dorbala","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1002\/ejhf.1756","article-title":"Light-chain and transthyretin cardiac amyloidosis in severe aortic stenosis: Prevalence, screening possibilities, and outcome","volume":"22","author":"Nitsche","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e005277","DOI":"10.1161\/CIRCIMAGING.116.005277","article-title":"Interstitial Fibrosis, Functional Status, and Outcomes in Heart Failure with Preserved Ejection Fraction: Insights from a Prospective Cardiac Magnetic Resonance Imaging Study","volume":"9","author":"Duca","year":"2016","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/ehjci\/jead188","article-title":"Myocardial structural and functional changes in cardiac amyloidosis: Insights from a prospective observational patient registry","volume":"25","author":"Duca","year":"2023","journal-title":"Eur. Heart J.-Cardiovasc. Imaging"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1002\/ehf2.14621","article-title":"Invasive haemodynamics at rest and exercise in cardiac amyloidosis","volume":"11","author":"Holt","year":"2023","journal-title":"ESC Heart Fail."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Saito, Y., Nakamura, K., and Ito, H. (2021). Molecular Mechanisms of Cardiac Amyloidosis. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23010025"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/ejhf.2016","article-title":"Prognostic value of cardiopulmonary exercise testing in cardiac amyloidosis","volume":"23","author":"Nicol","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.clml.2021.03.015","article-title":"Cardiopulmonary exercise testing in patients with Cardiac Amyloidosis","volume":"21","author":"Bhutani","year":"2021","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ehjci\/jey225","article-title":"Mechanisms of heart failure in transthyretin vs. light chain amyloidosis","volume":"20","author":"Binder","year":"2019","journal-title":"Eur. Heart J.-Cardiovasc. Imaging"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1080\/13506129.2018.1493989","article-title":"Right ventricular involvement in transthyretin amyloidosis","volume":"25","author":"Arvidsson","year":"2018","journal-title":"Amyloid"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s40477-023-00789-1","article-title":"Imaging findings of right cardiac amyloidosis: Impact on prognosis and clinical course","volume":"26","author":"Tana","year":"2023","journal-title":"J. Ultrasound"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1080\/13506129.2019.1620724","article-title":"Atrial fibrillation and subtype of atrial fibrillation in cardiac amyloidosis: Clinical and echocardiographic features, impact on mortality","volume":"26","author":"Sanchis","year":"2019","journal-title":"Amyloid"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/13506129.2015.1028616","article-title":"Atrial fibrillation in amyloidotic cardiomyopathy: Prevalence, incidence, risk factors and prognostic role","volume":"22","author":"Longhi","year":"2015","journal-title":"Amyloid"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1002\/ejhf.2650","article-title":"Atrial amyloidosis: Mechanisms and clinical manifestations","volume":"24","author":"Vergaro","year":"2022","journal-title":"Eur. J. Heart Fail."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jcmg.2021.06.022","article-title":"Clinical Importance of Left Atrial Infiltration in Cardiac Transthyretin Amyloidosis","volume":"15","author":"Bandera","year":"2022","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.amjcard.2020.07.034","article-title":"Digoxin Use in Cardiac Amyloidosis","volume":"133","author":"Donnelly","year":"2020","journal-title":"Am. J. Cardiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/01.CIR.63.6.1285","article-title":"Digoxin sensitivity in amyloid cardiomyopathy","volume":"63","author":"Rubinow","year":"1981","journal-title":"Circulation"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.jacep.2020.04.019","article-title":"Atrial Fibrillation in Transthyretin Cardiac Amyloidosis","volume":"6","author":"Donnellan","year":"2020","journal-title":"JACC Clin. Electrophysiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ijcard.2021.11.057","article-title":"Mode of death and outcomes of implantable cardioverter defibrillators in transthyretin amyloid cardiomyopathy","volume":"349","author":"Dale","year":"2021","journal-title":"Int. J. Cardiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1111\/pace.14023","article-title":"Primary prevention implantable cardioverter-defibrillators in transthyretin cardiac amyloidosis","volume":"43","author":"Donnellan","year":"2020","journal-title":"Pacing Clin. Electrophysiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1097\/TP.0000000000000574","article-title":"Liver Transplantation for Hereditary Transthyretin Amyloidosis: After 20 Years Still the Best Therapeutic Alternative?","volume":"99","author":"Ericzon","year":"2015","journal-title":"Transplantation"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1016\/j.healun.2024.02.1095","article-title":"Heart Transplant in Transthyretin Cardiac Amyloidosis: A Single-Center Experience","volume":"43","author":"Jacob","year":"2024","journal-title":"J. Heart Lung Transplant."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1016\/j.healun.2016.01.174","article-title":"Outcomes of Heart Transplantation for Transthyretin-Related Amyloid Cardiomyopathy","volume":"35","author":"Sabatino","year":"2016","journal-title":"J. Heart Lung Transplant."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Rocha, A., and Lobato, L. (Liver Transplant., 2015). Reply: Liver transplantation in transthyretin amyloidosis: Issues and challenges, Liver Transplant., online ahead of print.","DOI":"10.1002\/lt.24150"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1056\/NEJMoa2305434","article-title":"Efficacy and Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy","volume":"390","author":"Gillmore","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1056\/NEJMoa2300757","article-title":"Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis","volume":"389","author":"Maurer","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/13506129.2019.1685487","article-title":"Inotersen therapy of transthyretin amyloid cardiomyopathy","volume":"27","author":"Dasgupta","year":"2019","journal-title":"Amyloid"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1716793","article-title":"Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis","volume":"379","author":"Benson","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1080\/13506129.2022.2070470","article-title":"A natural history analysis of asymptomatic TTR gene carriers as they develop symptomatic transthyretin amyloidosis in the Transthyretin Amyloidosis Outcomes Survey (THAOS)","volume":"29","author":"Coelho","year":"2022","journal-title":"Amyloid"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/24\/7857\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:58:36Z","timestamp":1760115516000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/24\/7857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,23]]},"references-count":37,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["jcm13247857"],"URL":"https:\/\/doi.org\/10.3390\/jcm13247857","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,23]]}}}